European journal of haematology

Keyphrases

Publications

volume 113, number 1, 2024

Steven T Cox, Warren Patterson, Richard Duggleby, Owen J R Jones, J Alejandro Madrigal, Sergio Querol, Francesc Rudilla Salvador, Maria Jose Herrero Mata, Fernanda Volt, Éliane Gluckman, Richard Szydlo, Robert D Danby, Diana Hernandez
Impact of donor NKG2D and MICA gene polymorphism on clinical outcomes of adult and paediatric allogeneic cord blood transplantation for malignant diseases. European journal of haematology 113 (1) (2024)
Chie Ishikawa, Naoki Mori
Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia. European journal of haematology 113 (1) (2024)
Kittika Poonsombudlert, Sarah Mott, Benda Miller, Prajwal Dhakal, Anthony Snow, Sarah Hornberg, Ratdanai Yodsuwan, Christopher Strouse, Hira Shaikh, Margarida Magalhaes-Silverman, Grerk Sutamtewagul
Transplant versus no transplant in myelodysplastic syndrome and acute myeloid leukemia with TP53 mutation; a referral center experience. European journal of haematology 113 (1) (2024)
Saeid Taghiloo, Hossein Asgarian-Omran
Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review. European journal of haematology 113 (1) (2024)
Connor Frey, Hannah M Cherniawsky, Mahyar Etminan
Ocular adverse events following CAR-T cell therapy: A pharmacovigilance study and systematic review. European journal of haematology 113 (1) (2024)
John Donald Marra, Eugenio Galli, Sabrina Giammarco, Elisabetta Metafuni, Gessica Minnella, Federica Fosso, Sara Marietti, Simona Sica, Federica Sorà, Patrizia Chiusolo
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation. European journal of haematology 113 (1) (2024)
Rubina Shah, Andrew Y Finlay, Faraz Mahmood Ali, H Allen, S J Nixon, M Nixon, Kennedy Otwombe, John R Ingram, Sam S Salek
Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross-sectional study. European journal of haematology 113 (1) (2024)
Saeid Taghiloo, Hossein Asgarian-Omran
Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review. European journal of haematology 113 (1) (2024)
Jordan Nunnelee, Jithma Prasad Abeykoon, Aneel A Ashrani, Michelle Ann Elliott, C Christopher Hook, Animesh Pardanani, Rajiv K Pruthi, Rachelle L Rouse, Meera Sridharan, Alexandra P Wolanskyj-Spinner, Ronald S Go
C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomes. European journal of haematology 113 (1) (2024)
Lucas Maahs, Pritesh R Patel, Matthew Koshy, Karen I Sweiss, Zhengjia Chen, Ziqiao Xu, Bulent Aydogan, Damiano Rondelli
High dose total marrow irradiation (TMI) does not increase long-term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT). European journal of haematology 113 (1) (2024)
Chie Ishikawa, Naoki Mori
Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia. European journal of haematology 113 (1) (2024)
Carl Inge Edvard Smith, Rula Zain
Reduced clone size upon BTK inhibitor resistance mutations relates to toxicity caused by inherited PLCG2 gain-of-function variations. European journal of haematology 113 (1) (2024)
Jordan Nunnelee, Jithma Prasad Abeykoon, Aneel A Ashrani, Michelle Ann Elliott, C Christopher Hook, Animesh Pardanani, Rajiv K Pruthi, Rachelle L Rouse, Meera Sridharan, Alexandra P Wolanskyj-Spinner, Ronald S Go
C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomes. European journal of haematology 113 (1) (2024)

volume 113, number 2, 2024

Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella Mesa, Michele Cavo, Meletios- Athanasios Dimopoulos, Martina Bianco, Giovanni Marino Merlo, Charles la Porte, Paul Gerard Richardson, Phillipe Moreau
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial. European journal of haematology 113 (2) (2024)
Minna Harmanen, Marc Sorigue, Madiha Khan, Roosa Prusila, Tuula Klaavuniemi, Esa Kari, Esa Jantunen, Kaisa Sunela, Aino Rajamäki, Erika Alanne, Hanne Kuitunen, Arja Jukkola, Juan-Manuel Sancho, Outi Kuittinen, Aino Rönkä
Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis. European journal of haematology 113 (2) (2024)
Tim Richardson, Christof Scheid, Marco Herling, Lukas P Frenzel, Carmen Herling, Marta Rebecca Cruz Aguilar, Sebastian Theurich, Michael Hallek, Udo Holtick
Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trial. European journal of haematology 113 (2) (2024)
Adam L Urback, Kylee L Martens, Hannah Stowe McMurry, Anil Sharma, Caitlin Citti, Thomas G DeLoughery, Joseph J Shatzel
Serum ferritin and risk of colonic neoplasia: Implications for the workup and treatment of iron deficiency. European journal of haematology 113 (2) (2024)
Adam L Urback, Kylee L Martens, Hannah Stowe McMurry, Anil Sharma, Caitlin Citti, Thomas G DeLoughery, Joseph J Shatzel
Serum ferritin and risk of colonic neoplasia: Implications for the workup and treatment of iron deficiency. European journal of haematology 113 (2) (2024)
Adam L Urback, Kylee L Martens, Hannah Stowe McMurry, Anil Sharma, Caitlin Citti, Thomas G DeLoughery, Joseph J Shatzel
Serum ferritin and risk of colonic neoplasia: Implications for the workup and treatment of iron deficiency. European journal of haematology 113 (2) (2024)
Minna Harmanen, Marc Sorigue, Madiha Khan, Roosa Prusila, Tuula Klaavuniemi, Esa Kari, Esa Jantunen, Kaisa Sunela, Aino Rajamäki, Erika Alanne, Hanne Kuitunen, Arja Jukkola, Juan-Manuel Sancho, Outi Kuittinen, Aino Rönkä
Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis. European journal of haematology 113 (2) (2024)
B Pernas, Gloria Iacoboni, I Los-Arcos, C Carpio, E Márquez-Algaba, M A Sanchez-Salinas, A Albasanz, J Esperalba, B Viñado, I Ruiz Camps, Pere Barba
Patients with aggressive B-cell lymphoma receiving CAR T-cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis. European journal of haematology 113 (2) (2024)
Nadine Kutsch, Adam Giza, Sandra Robrecht, Janina Stumpf, Anno Federhen, Andrea Stoltefuß, Ursula Vehling-Kaiser, Michael Koenigsmann, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Thomas Illmer, Rudolf Schlag, Steffen Dörfel, Tobias Gaska, Michael Kiehl, Sigrun Müller-Hagen, Enno Moorahrend, Hartmut Linde, Anke Schlenska-Lange, Julia von Tresckow, Kirsten Fischer, Barbara Eichhorst, Michael Hallek, Anna Maria Fink
Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry. European journal of haematology 113 (2) (2024)
Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella Mesa, Michele Cavo, Meletios- Athanasios Dimopoulos, Martina Bianco, Giovanni Marino Merlo, Charles la Porte, Paul Gerard Richardson, Phillipe Moreau
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial. European journal of haematology 113 (2) (2024)
Adam L Urback, Kylee L Martens, Hannah Stowe McMurry, Anil Sharma, Caitlin Citti, Thomas G DeLoughery, Joseph J Shatzel
Serum ferritin and risk of colonic neoplasia: Implications for the workup and treatment of iron deficiency. European journal of haematology 113 (2) (2024)
Miklos Egyed, Tóth Peter Oliver, Kellner Adam, Karadi Eva, Kollar Balazs, Kovacs Eszter, Pavlovics Anett, Gyori-Korom Viktoria, Herczeg Jozsef, Rajnics Peter
Fix low dose venetoclax-azacitidine treatment of unfit acute myeloid leukemia patients. European journal of haematology 113 (2) (2024)
Crhistian-Mario Oblitas, Pablo Demelo-Rodríguez, Marina López-Rubio, Marta-Olimpia Lago-Rodríguez, Mercedes García-Gámiz, Angielys Zamora-Trillo, Luis-Antonio Alvarez-Sala Walther, Rita García-Martínez, Francisco Galeano-Valle
Evaluation of soluble P-selectin as a predictive biomarker in acute symptomatic pulmonary embolism: Insights from a prospective observational study. European journal of haematology 113 (2) (2024)
Hans C Lee, Karthik Ramasamy, Margaret Macro, Faith E Davies, Rafat Abonour, Frits van Rhee, Vania T M Hungria, Noemi Puig, Kaili Ren, Jiri Silar, Victoria Enwemadu, Dasha Cherepanov, Xavier Leleu
Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study. European journal of haematology 113 (2) (2024)
Crhistian-Mario Oblitas, Pablo Demelo-Rodríguez, Marina López-Rubio, Marta-Olimpia Lago-Rodríguez, Mercedes García-Gámiz, Angielys Zamora-Trillo, Luis-Antonio Alvarez-Sala Walther, Rita García-Martínez, Francisco Galeano-Valle
Evaluation of soluble P-selectin as a predictive biomarker in acute symptomatic pulmonary embolism: Insights from a prospective observational study. European journal of haematology 113 (2) (2024)
Emma P DeLoughery
Global prevalence of anemia among women of reproductive age, 2000-2019. European journal of haematology 113 (2) (2024)
Tim Richardson, Christof Scheid, Marco Herling, Lukas P Frenzel, Carmen Herling, Marta Rebecca Cruz Aguilar, Sebastian Theurich, Michael Hallek, Udo Holtick
Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trial. European journal of haematology 113 (2) (2024)
Mariane De Montalembert, Alan R Anderson, Fernando Ferreira Costa, Baba Psalm Duniya Inusa, Omima Mustafa, Joachim B Kunz, Biba Tinga, Elvie Ingoli, John James, Regina Hartfield, Anne Beaubrun, Belinda Lartey, Isaac Odame
Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) survey: Perspectives of adolescent and adult patients, caregivers, and healthcare professionals on the burden of sickle cell disease. European journal of haematology 113 (2) (2024)
Emma P DeLoughery
Second-generation antipsychotics and VTE risk. European journal of haematology 113 (2) (2024)
Catherine Aftandilian, Xue Rachel Bito, David Berman, Amy Zhang, Radha Duttagupta, Kara L Davis
Plasma microbial cell-free DNA following chimeric antigen receptor T cell therapy in pediatric patients with relapsed/refractory leukemia. European journal of haematology 113 (2) (2024)
Lital Yeshareem, Joanne Yacobovich, Asaf Lebel, Sharon Noy-Lotan, Orly Dgany, Tanya Krasnov, Galit Berger Pinto, Nino Oniashvili, Jacques Mardoukh, Bella Bielorai, Ruth Laor, Noa Mandel-Shorer, Ayelet Ben Barak, Carina Levin, Mahdi Asleh, Hagit Miskin, Shoshana Revel-Vilk, Dror Levin, Marganit Benish, Tsila Zukerman, Ofir Wolach, Idit Pazgal, Dafna Brik Simon, Oded Gilad, Asaf David Yanir, Tracie Alison Goldberg, Shai Izraeli, Hannah Tamary, Orna Steinberg-Shemer
Genetic backgrounds and clinical characteristics of congenital neutropenias in Israel. European journal of haematology 113 (2) (2024)

volume 113, number 3, 2024

Shaofen Lin, Ning Liao, Xin-Yu Li, Lihua Yang, Yun-Yan He, Yan-Lai Tang, Wu-Qing Wan, Wenguang Jia, Ya-Jie Zhang, Qian Kong, Xingjiang Long, Xiang Lan, Ya-Yun Ling, Danna Lin, Xiao-Li Zhang, Chuan Wen, Chi-Kong Li, Hong-Gui Xu
Prognosis of pediatric BCP-ALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG-2016 study. European journal of haematology 113 (3) (2024)
Jasmine Lewis, Gregory M T Guilcher, Steven C Greenway
Reviewing the impact of hydroxyurea on DNA methylation and its potential clinical implications in sickle cell disease. European journal of haematology 113 (3) (2024)
Olivier Decaux, Jean Fontan, Aurore Perrot, Lionel Karlin, Cyrille Touzeau, Samantha Schulmann, Salomon Manier, Karim Belhadj, Adrien Trebouet, Patricia Zunic, Jean-Marc Schiano De Colella, Brice Castel, Zoé Van De Wyngaert, Gian Matteo Pica, Mourad Tiab, Frédérique Kuhnowski, Malek Bouketouche, Sophia Rigaudeau, Riad Benramdane, Christina Tekle, Radhia Lafore, Marianne Gaucher, Jill Corre, Xavier Leleu
Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world: The retrospective IMAGE study. European journal of haematology 113 (3) (2024)
Patrick M Vanderboom, Yogesh Chawla, Surendra Dasari, Isha Kapoor, Shaji K Kumar, K Sreekumaran Nair, Wilson I Gonsalves
Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders. European journal of haematology 113 (3) (2024)
Patrick M Vanderboom, Yogesh Chawla, Surendra Dasari, Isha Kapoor, Shaji K Kumar, K Sreekumaran Nair, Wilson I Gonsalves
Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders. European journal of haematology 113 (3) (2024)
Chetan Jeurkar, Benjamin Leiby, Shaik Rashid, Usama Gergis, Dolores Grossso, Matthew Carabasi, Joanne Filicko-O'Hara, William O'Hara, Thomas Klumpp, Pierluigi Porcu, Neal Flomenberg, John L Wagner
A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose. European journal of haematology 113 (3) (2024)
Patrick M Vanderboom, Yogesh Chawla, Surendra Dasari, Isha Kapoor, Shaji K Kumar, K Sreekumaran Nair, Wilson I Gonsalves
Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders. European journal of haematology 113 (3) (2024)
Neeti Luke, Kristyn A Pierce, Kirsty Hillier
Cytokine expression in pediatric patients with immune thrombocytopenia (ITP) in different phases of disease. European journal of haematology 113 (3) (2024)
Melina Sophie Kurte, Ann-Cathrine Siefen, Florian Jakobs, Tabea Poos, Julia von Tresckow, Bastian von Tresckow, Hans Christian Reinhardt, Florian Kron
Time-dependent cost comparison and health economic impact analysis of second-line interventions for transplant-ineligible patients with relapsed or refractory diffuse large B cell lymphoma. European journal of haematology 113 (3) (2024)
Caseng Zhang, Danielle Charland, Katharine O'Hearn, MacGregor Steele, Robert J Klaassen, Matthew Speckert
Childhood autoimmune hemolytic anemia: A scoping review. European journal of haematology 113 (3) (2024)
Nishit B Modi, Richard Shames, Jason D Lickliter, Suneel Gupta
Pharmacokinetics, pharmacodynamics, and tolerability of an aqueous formulation of rusfertide (PTG-300), a hepcidin mimetic, in healthy volunteers: A double-blind first-in-human study. European journal of haematology 113 (3) (2024)
Jorge Vela-Ojeda, Ana Cristina Olivas-Bejarano, Laura Arcelia Montiel-Cervantes, Erika Rosales-Cruz, Socrates Garcia-Gutierrez, Ruth Angelica Lezama-Palacios, Elba Reyes-Maldonado
Soluble MIC-A, IPI, and response to treatment strongly predict survival in patients with germinal center diffuse large B cell lymphoma. European journal of haematology 113 (3) (2024)
Murielle Roussel, Nathalie Texier, Virginie Nael, Jacopo Bitetti, Prani Paka, Naima Kerbouche, Lynda Sail, Xavier Colin, Xavier Leleu
Effectiveness and safety of belantamab mafodotin in patients with relapsed or refractory multiple myeloma in real-world setting: The ALFA study. European journal of haematology 113 (3) (2024)
Patrick M Vanderboom, Yogesh Chawla, Surendra Dasari, Isha Kapoor, Shaji K Kumar, K Sreekumaran Nair, Wilson I Gonsalves
Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders. European journal of haematology 113 (3) (2024)
Rikke Faebo Larsen, Mary Jarden, Lisbeth Rosenbek Minet, Ulf Christian Frølund, Anne Pernille Hermann, Leif Breum, Sören Möller, Niels Abildgaard
Exercise in newly diagnosed patients with multiple myeloma: A randomized controlled trial of effects on physical function, physical activity, lean body mass, bone mineral density, pain, and quality of life. European journal of haematology 113 (3) (2024)
N Mauz, M Bouisse, Jean-Yves Cahn, Eléonore Kaphan, Anne-Sophie Truche, A Thiebaut-Bertrand, M Carré, Claude-Eric Bulabois, R Hamidfar-Roy, Carole Schwebel, Sophie Park, José Labarère, Nicolas Terzi
Rapid response system for critically ill patients with haematological malignancies: A pre- and post-intervention study. European journal of haematology 113 (3) (2024)